Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases.

Graham RP, Shrestha B, Caron BL, Smyrk TC, Grogg KL, Lloyd RV, Zhang L.

Am J Surg Pathol. 2013 Mar;37(3):399-405. doi: 10.1097/PAS.0b013e31826f042c.

PMID:
23348208
2.

Neuroendocrine tumor disease: an evolving landscape.

Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM.

Endocr Relat Cancer. 2012 Sep 14;19(5):R163-85. doi: 10.1530/ERC-12-0024. Print 2012 Oct. Review.

3.

Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.

Anlauf M.

Horm Metab Res. 2011 Nov;43(12):825-31. doi: 10.1055/s-0031-1291307. Epub 2011 Nov 21. Review.

PMID:
22105474
4.

Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.

Bellizzi AM.

Adv Anat Pathol. 2013 Sep;20(5):285-314. doi: 10.1097/PAP.0b013e3182a2dc67. Review.

PMID:
23939147
5.

Pancreatic Neuroendocrine Neoplasms.

Rosenbaum JN, Lloyd RV.

Surg Pathol Clin. 2014 Dec;7(4):559-75. doi: 10.1016/j.path.2014.08.005. Epub 2014 Nov 8. Review.

PMID:
26837555
6.

Appendiceal neuroendocrine neoplasms: diagnosis and management.

Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB.

Endocr Relat Cancer. 2016 Jan;23(1):R27-41. doi: 10.1530/ERC-15-0310. Epub 2015 Oct 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk